Silicon Valley Veterans Sarah Imbach and Larry Tesler Join 23andMe Management Team

December 18, 2008

Imbach, Former Vice-President of Revenue and Customer Operations at LinkedIn Named Chief Operating Officer; Tesler, Former Vice President of User Experience and Design at Yahoo! Named Product Fellow

Mountain View, Calif. – December 18, 2008 – 23andMe, Inc., the industry leader in personal genetics, announced today that it has hired two seasoned executives from the start-up and technology worlds to serve in top management positions at the company. Sarah Imbach, who most recently worked as LinkedIn’s Vice-President of Revenue and Customer Operations, will be 23andMe’s Chief Operating Officer, starting January 12, 2009. Larry Tesler, former VP of User Experience and Design at Yahoo!, recently joined 23andMe as Product Fellow. Ms. Imbach is an experienced consumer internet start-up executive and generalist in all areas of operations including finance, human resources, product, sales, customer service and risk. During her four and a half years at LinkedIn, she helped grow the company from 25 to 340 employees, from less than one million to more than thirty-two million users, and from zero revenue to profitability. Prior to that, she was an independent management consultant, working with several well-funded start-ups and also served as Senior Vice President, Customer Service Operations and Fraud at PayPal. Ms. Imbach will bring her considerable experience developing start-ups to bear at 23andMe, where she will manage the day-to-day operations of the business, including operations, finance and administration, product, engineering, and business development. Mr. Tesler has over forty years of management and technical experience in the computer industry. He most recently worked at Yahoo! as Vice President of User Experience & Design and Research Fellow. Previously, he served as Vice President of Shopping Experience at Amazon.com, President of Stagecast, and Vice President and Chief Scientist of Apple. His early career included positions at the Xerox Palo Alto Research Center (PARC) and the Stanford University Department of Genetics. As Product Fellow at 23andMe, Mr. Tesler will advise and support the product and science teams, focusing on innovation, customer experience, and strategic planning. Ms. Imbach said, “I have worked in the startup world for most of my career and have always enjoyed helping new companies and entrepreneurs take their innovative visions to the next level. 23andMe is on the forefront of a new industry that has the potential to transform health care and the public’s understanding of genetics, and I am excited to help the company realize this potential.” Mr. Tesler echoed this sentiment. “23andMe has a fantastic group of creative and dedicated people. The Personal Genome Service they have developed is intriguing, but it’s just the beginning. We have new projects in the pipeline to enhance the user experience and further our goal of making genetics accessible to consumers.” “We are thrilled to have Sarah and Larry join our rapidly expanding team,” said Linda Avey, 23andMe co-founder. “The past year has been one of consistent growth and development for 23andMe. It will be a great benefit to have Sarah and Larry help guide the company in the coming year as we continue to launch new products and services and broaden our research initiatives.”
Joining the 23andMe Community
To learn more and embark on your own personal genetics journey, please visit:
www.23andme.com. 23andMe is now available to consumers in the following locations: Albania, American Samoa, Armenia, Australia, Austria, Azerbaijan, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Guam, Hungary, Iceland, Ireland, Israel, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Macedonia, Malta, Moldova, Monaco, Montenegro, Netherlands, New Zealand, Northern Mariana Islands, Norway, Poland, Portugal, Puerto Rico, Romania, San Marino, Serbia, Singapore, Slovakia, Slovenia, Spain, Sweden, Switzerland, United Kingdom, United States, Vatican City and Virgin Islands, U.S..

About 23andMe

23andMe, Inc., headquartered in Sunnyvale, CA, is a leading consumer genetics and research company. Founded in 2006, the company’s mission is to help people access, understand, and benefit from the human genome. 23andMe has pioneered direct access to genetic information as the only company with multiple FDA clearances for genetic health reports. The company has created the world’s largest crowdsourced platform for genetic research, with 80% of its customers electing to participate. The 23andMe research platform has generated more than 180 publications on the genetic underpinnings of a wide range of diseases. The platform also powers the 23andMe Therapeutics group, currently pursuing drug discovery programs rooted in human genetics across a spectrum of disease areas, including oncology, respiratory, and cardiovascular diseases, in addition to other therapeutic areas. More information is available at www.23andMe.com.